Notable Research Findings

The most groundbreaking individual studies from the latest supplement and nutrition research — in plain language, with the evidence caveats built in. Research signals worth knowing about, not health advice.

A 9-day trial of vitamin B3 (plus B6) saw muscle stem cell markers rise 29–67% after intense exercise — but only in healthy young men, and the evidence is brand new.
- 2026-03-24
- RCT
- Advanced science (Weinheim, Baden-Wurttemberg, Germany)
This is the first controlled human trial to link a specific dose of nicotinamide and pyridoxine to more active muscle stem cells after damage, but because it's a single, small, short-term study in a narrow population, the finding is intriguing but far from actionable.
New evidenceVitamin B3 for Increased Muscle Stem Cell Count
Seven clinical studies on vitamin B1 for blood sugar control all came up empty — the review found no significant effect on hyperglycemic response.
- 2025-04-22
- Systematic Review
- International journal of molecular sciences
Despite hints from lab research that thiamine might help with diabetes, this systematic review of seven clinical trials found no measurable benefit for blood sugar spikes, cardiovascular risk, or insulin sensitivity — meaning the popular belief that B1 supplements can tame post-meal glucose remains unsupported by decent human data.
Myth-busterVitamin B1 for Reduced Hyperglycemic Response
Fish oil lowered depression scores by 10 points in an 8-week trial — but the study was small and other health markers like blood sugar and cholesterol didn't budge
- 2025-07
- RCT
- n = 57
- Journal of affective disorders
This is one of the first controlled trials to show such a large effect on depression symptoms, but with only 57 participants and a clinical population, the result needs replication before it can be generalized.
Big effectFish Oil for Reduced Depression Symptoms
Bitter orange essential oil boosted odds of lower systolic pressure 17-fold in a hand-surgery trial — but the finding comes from a single RCT in a very specific clinical setting.
- 2025-07-06
- RCT
- n = 76
- Pain management
This is the first controlled trial to link bitter orange (Citrus Aurantium) with a large drop in systolic blood pressure, but because the study involved only 76 post-surgery patients and the exact dose wasn't reported, we can't yet assume the same effect would occur in healthy people taking it outside a hospital.
New evidenceBitter Orange for Reduced Systolic Blood Pressure
A 24-week trial linked daily jiaogulan tea to a threefold increase in hair elasticity — but left glossiness unchanged.
- 2025-02-21
- RCT
- Nutrients
This is the first controlled trial to suggest jiaogulan can improve hair structure, but the finding is still preliminary — the effect on shine was absent, and the study stands alone without replication.
Surprisingjiaogulan for Increased Hair Elasticity
All-cause mortality was statistically indistinguishable (RR 0.94, p=0.57) between vitamin K antagonists and DOACs in a meta-analysis of 3,863 heart valve patients — a null finding from a specific clinical context, not a verdict on vitamin K supplements.
- 2026-01
- Meta-Analysis
- n = 3,863
- Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
This doesn't test whether vitamin K supplements affect mortality; it compares two types of anticoagulant drugs in a narrow patient group. The result means that in this population, blocking vitamin K's action (via warfarin) didn't shift death rates compared to newer alternatives — a reminder that sweeping claims about vitamin K and longevity need far more evidence.
Myth-busterVitamin K for Reduced All-Cause Mortality
In a triple-blind trial, a single 200 mg dose of bromelain led to more chewing pain at 48 hours than ibuprofen — though it matched ibuprofen for pain intensity earlier.
- 2025-04-01
- RCT
- n = 135
- Clinical and experimental dental research
This finding complicates the common belief that bromelain is a straightforward pain reliever, but the result is narrow — limited to chewing pain at one time point in a single small study, so the picture is far from settled.
Myth-busterBromelain for Reduced Chewing Pain
Moringa linked to a moderate drop in diastolic blood pressure — but the meta-analysis rates the evidence as very low certainty.
- 2025-11-07
- Meta-Analysis
- n = 341
- Nutrients
This is the first pooled analysis on moringa and blood pressure, but with only three small trials and a 'very low' GRADE rating, the result is too shaky to act on — especially since other cardiometabolic outcomes didn't budge.
New evidenceMoringa for Reduced Diastolic Blood Pressure
Taurine plus medication boosted a key cognitive test by 3 points in a meta-analysis — but only in a clinical subgroup, and taurine alone showed no benefit.
- 2025-05-04
- Meta-Analysis
- n = 402
- International journal of food sciences and nutrition
This is the first meta-analysis to suggest taurine might enhance cognition when paired with therapeutic drugs, but it's a single early result from a small clinical population — not a green light for healthy people to expect brain gains.
New evidenceTaurine for Improved Cognitive Performance
In obese men, 200 mg/day fisetin plus interval training led to weight loss over 12 weeks — but the supplement alone also worked, and the study didn't compare it to training alone.
- 2026-01-28
- RCT
- Nutrients
This is among the first controlled trials to test fisetin for weight loss in humans, so the results are intriguing but far from conclusive — especially since the study was small and didn't specify sample size.
New evidenceFisetin for Reduced Body Weight
Vitamin D supplements in overweight children were linked to a drop in 'good' HDL cholesterol — the only cardiometabolic marker that budged at all.
- 2025-11-25
- Meta-Analysis
- n = 440
- BMC pediatrics
This small, low-quality meta-analysis of just 3 studies found that vitamin D actually lowered HDL cholesterol in overweight kids, but the overall evidence is too weak and contradictory to say vitamin D is harmful — it just means the popular idea that it automatically improves heart health in this group is now contested.
Myth-busterVitamin D for Increased HDL Cholesterol Levels
Resveratrol from red grapes showed mixed results in a systematic review of 3,582 people — with some side effects reported, no clear cognitive benefit emerged.
- 2025-10-31
- Systematic Review
- n = 3,582
- International journal of molecular sciences
This review of clinical trials on natural products for Alzheimer's found resveratrol's effects on cognition were inconsistent and not statistically significant, meaning the popular idea that red grape compounds reliably protect memory is now contested — though the evidence is still early and varied.
Myth-busterRed Grape for Improved Cognitive Function
In a 5-day ICU trial, Streptococcus salivarius improved oral hygiene scores by nearly 2 points while controls deteriorated — but the results come from a small, specific clinical population
- 2026-02-03
- RCT
- BMC infectious diseases
This is among the first controlled studies on this probiotic for oral health, so the finding is promising but far from established — especially since it only applies to critically ill patients on ventilators, not the general public.
New evidenceStreptococcus salivarius for Improved Oral Health
A systematic review of 134 patients suggests propolis mouthwash may reduce the severity of radiation-induced mouth sores — but the evidence is still early and based on a small number of studies.
- 2026
- Systematic Review
- n = 134
- Brazilian journal of biology = Revista brasleira de biologia
This is the first solid signal that propolis could help with a painful side effect of head and neck cancer treatment, but with only 134 patients and no standard dosing, it's too soon to treat it as a proven remedy.
New evidencePropolis for Reduced Oral Mucositis Severity
A systematic review of 428 patients found Ginkgo biloba lowered eye pressure by just 1.5 mmHg (95% CI -7.1 to 9.6, P = 0.5) — a statistically null result that contradicts the popular belief it helps glaucoma.
- 2025-02-14
- Systematic Review
- n = 428
- PloS one
As one of the first systematic reviews to formally test this popular pairing, the null result strongly contests the prevailing belief that Ginkgo helps eye pressure — but the wide confidence interval and short follow-up (median 3.7 months) mean the question isn't fully closed.
Myth-busterGinkgo for Reduced Intraocular Pressure
Pomegranate supplementation linked to a 0.39 mmHg drop in diastolic blood pressure in a meta-analysis — but other heart risk markers didn't budge
- 2025-10
- Meta-Analysis
- n = 2,306
- Nutrition, metabolism, and cardiovascular diseases : NMCD
This is one of the first large-scale analyses to suggest pomegranate may lower diastolic pressure, but the effect is modest (less than half a millimeter of mercury) and the same analysis found no improvement in insulin resistance or waist-to-hip ratio, so the overall picture is still uncertain.
Big effectpomegranate for Reduced Diastolic Blood Pressure
Propolis mouthwash slashed cavity-causing bacteria by more than a factor of 10 in people with braces — but the effect may not translate to everyone.
- 2025-12
- RCT
- n = 120
- International orthodontics
This is one of the first rigorous trials to test propolis against cavity bacteria, and the result is unusually large — but until it's replicated in broader populations, consider it a promising early signal, not a settled fact.
Big effectPropolis for Reduced Streptococcus Mutans Levels
Saffron slashed white blood cell counts by over 4,000 units in sepsis patients — but only in a seven-day ICU trial with no effect on mortality.
- 2025-05-09
- RCT
- Nutrition journal
This is a striking signal from a small, short-term clinical study, but it's the first of its kind and didn't translate to a survival benefit, so the finding is intriguing but far from actionable for healthy people.
Big effectSaffron for Reduced White Blood Cell Count
A 90-day trial linked 500 mg/day quercetin to a large increase in a bone-formation marker — but also a similarly large increase in a bone-breakdown marker, leaving the net effect unclear.
- 2025-03-07
- RCT
- Journal of bone and mineral metabolism
This is among the first trials on quercetin for bone health in postmenopausal women, so the conflicting signals warrant caution — the supplement may accelerate bone turnover rather than protect against loss.
SurprisingQuercetin for Increased Osteocalcin Level
Propolis linked to 65% lower odds of chemo mouth sores in a meta-analysis — but the studies weren't blinded and the total evidence is still thin.
- 2025-04-07
- Meta-Analysis
- Endocrine, metabolic & immune disorders drug targets
This early meta-analysis suggests propolis might offer real relief for a painful side effect of chemotherapy, but the lack of blinding and small number of studies means the result is far from settled.
TrendingPropolis for Improved Oral Mucositis
A 544-patient meta-analysis found that pairing plant compounds like peony with standard psoriasis therapy dramatically outperformed standard care — with one compound cutting the PASI index by nearly 14 points — though peony's specific benefit was on immune markers rather than raw severity scores.
- 2026-06-22
- Systematic Review
- n = 544
- Frontiers in medicine
This is among the first indexed studies to systematically review peony for psoriasis, so the findings are promising but need replication — especially since the biggest severity score drop in the analysis came from a different plant compound.
Big effectPeony for Reduced Psoriasis Area and Severity Index
Ginkgo cut dizziness severity by 0.76 points on an 11-point scale in a meta-analysis — but nearly all the evidence came from dementia patients, leaving the real-world reach unclear.
- 2026-06-18
- Systematic Review
- Frontiers in neurology
This is the first systematic review to pull together multiple trials on ginkgo for dizziness in people with brain disorders, so it's a meaningful step forward — but the results come from a narrow patient group and the studies varied widely, so treat the finding as promising, not settled.
New evidenceGinkgo for Reduced Dizziness Severity
Eating 80 grams of sorghum daily for 12 weeks shrank visceral fat in Japanese adults with excess belly fat — but the same study found no effect on a liver enzyme tied to metabolic health.
- 2026-06-11
- Clinical Trial
- Nutrients
This is among the first clinical trials to test sorghum for visceral fat loss, so the finding is intriguing but far from settled — especially since it was a small, single-arm (uncontrolled) study in a specific population, and a related marker of liver stress didn't budge.
Surprisingsorghum for Reduced Visceral Fat
A 5-week trial of 10 g/day soy protein improved insulin sensitivity in overweight adolescent boys — but the effect is from a single, small study in a narrow population.
- 2026-06-23
- RCT
- Nutrients
This is early evidence that soy protein might help with insulin sensitivity, but with only one study in a specific group (overweight teenage boys) and a short duration, it's far from a universal recommendation.
New evidenceSoy Protein for Improved Insulin Sensitivity
A systematic review of 7 studies found no evidence that protein helps older adults with multiple chronic conditions build muscle — but only 2 of those studies actually tested protein.
- 2026-08
- Systematic Review
- n = 932
- Clinical nutrition ESPEN
This doesn't disprove protein's role in muscle health; it reveals that the existing research simply hasn't asked the right question in this specific population, so the popular belief that protein is a reliable muscle booster for all older adults is now contested for those with multiple long-term conditions.
Myth-busterProtein for Improved Muscle Mass
Coffee after C-section cut time to first gas by 2.75 hours in a meta-analysis — but the evidence rests on a small set of low-quality trials.
- 2026-02-04
- Meta-Analysis
- n = 555
- BMC public health
This is the first pooled analysis on coffee and post-surgical flatulence, and while the reduction is real in these studies, the underlying trials were small and unblinded, so the effect may shrink — or vanish — once better research comes in.
New evidenceCoffee for Reduced Flatulence
Black cohosh failed to beat placebo in two RCTs — a systematic review finds the evidence for hot flash relief is thin and mixed.
- 2026-06-23
- Systematic Review
- Nutrients
This null result undermines the popular belief that black cohosh reliably reduces menopausal hot flashes, but with only three studies total (one positive, two neutral), the picture is far from settled — the overall strength of the evidence is low.
Myth-busterBlack Cohosh for Reduced Vasomotor Symptom
Resveratrol lowered diastolic blood pressure by 3.55 mmHg in type 2 diabetes patients — a clean signal from a meta-analysis, but the benefit hasn't been tested in healthy people.
- 2026-04-15
- Meta-Analysis
- Nutrition journal
This is one of the first rigorous summaries to pin a specific, moderate-sized drop in diastolic pressure on resveratrol, but because the effect was seen only in people with type 2 diabetes, it's too early to assume the same would happen for someone without that condition.
Big effectResveratrol for Reduced Diastolic Blood Pressure
Ashwagandha slashed cortisol by a large margin in a meta-analysis of 1,706 adults — but the same study found no effect on TSH, T3, or estradiol.
- 2026-02-25
- Meta-Analysis
- n = 1,706
- Planta medica
This is among the first pooled analyses on ashwagandha and cortisol, so the result is promising but far from settled — especially since the underlying trials weren't blinded, which can inflate perceived benefits.
TrendingAshwagandha for Reduced Cortisol Levels
A meta-analysis tied higher coffee consumption to a 48% greater odds of heart attack — yet the same review found it protective against stroke and arrhythmia.
- 2026-05-07
- Meta-Analysis
- n = 2
- BMC cardiovascular disorders
This finding flips the usual narrative that coffee is mostly protective for the heart, but it comes from a tiny pool of just two studies and contradicts the review’s own results for other cardiovascular outcomes, so the picture is now contested rather than settled.
Myth-busterCoffee for Reduced Myocardial Infarction Risk